Peyronie's Disease Clinical Trial
Official title:
A Sequential, Randomized, Double-blind, Placebo-controlled, Prospective Study to Evaluate the Safety and Efficacy of the H-100 Treatment in Adult Male Volunteers With Peyronie's Disease
Treatment of Peyronie's disease remains difficult. The purpose of this study is to test the safety and efficacy of a new compound to treat this disease.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01685437 -
A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
|
Phase 3 | |
| Completed |
NCT01430169 -
Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
|
Phase 2 | |
| Completed |
NCT01221597 -
Study of AA4500 in the Treatment of Peyronie's Disease
|
Phase 3 | |
| Recruiting |
NCT05108558 -
Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders
|
Phase 4 | |
| Recruiting |
NCT05147779 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis
|
Phase 1 | |
| Recruiting |
NCT03767452 -
Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response
|
Phase 4 | |
| Completed |
NCT02267460 -
An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
|
Phase 3 | |
| Completed |
NCT01221623 -
Study of AA4500 in the Treatment of Peyronie's Disease
|
Phase 3 | |
| Completed |
NCT02298829 -
Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease
|
||
| Completed |
NCT01243411 -
A Study of AA4500 in Men With Peyronie's Disease
|
Phase 3 | |
| Completed |
NCT01578473 -
Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
|
Phase 1 | |
| Not yet recruiting |
NCT05855070 -
Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease
|
N/A | |
| Terminated |
NCT05873595 -
Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease
|
||
| Active, not recruiting |
NCT04786106 -
Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's
|
Phase 4 | |
| Completed |
NCT00812838 -
H-22411: BOTOX® for Peyronie's Disease
|
Phase 2 | |
| Completed |
NCT02395029 -
Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD
|
Phase 1 | |
| Completed |
NCT00755222 -
The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease
|
Phase 2 |